Should you buy DNA stock?
Last updated:
Based on market data through , StockInvest.us rates Ginkgo Bioworks (DNA) as a Sell Candidate with a technical score of -3.87 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 6.24%
- 3-month trend forecast Up 0.82%
- Easy Tracking In The Watchlist
High volatility in Ginkgo Bioworks stock price on Friday which ended trading at $7.97
(Market data through Aug 07, 2026)
The Ginkgo Bioworks stock price fell by -6.24% on the last day (Friday, 7th Aug 2026) from $8.50 to $7.97. During the last trading day the stock fluctuated 11.75% from a day low at $7.49 to a day high of $8.37. The price has risen in 5 of the last 10 days and is up by 8.29% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -81 thousand shares and in total, 2 million shares were bought and sold for approximately $13.18 million.
The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $7.37 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Ginkgo Bioworks stock with a 90% probability to be traded between $7.43 and $10.52 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
DNA Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ginkgo Bioworks stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.62 and $8.85. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, August 05, 2026, and so far it has fallen -14.94%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Ginkgo Bioworks stock
Ginkgo Bioworks finds support from accumulated volume at $7.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.88 between high and low, or 11.75%. For the last week, the stock has had daily average volatility of 8.92%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (DNA) For The Upcoming Trading Day Of Monday 10th
For the upcoming trading day on Monday, 10th we expect Ginkgo Bioworks Holdings, Inc. to open at $7.94, and during the day (based on 14 day Average True Range), to move between $7.65 and $8.29, which gives a possible trading interval of +/-$0.646 (+/-8.45%) up or down from last closing price. If Ginkgo Bioworks Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 8.45% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $7.91 (0.75%) than the resistance at $9.05 (13.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Ginkgo Bioworks Holdings, Inc. stock A Buy?
Ginkgo Bioworks holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-3.872
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 10, 2026 - $7.94 ( 0.335%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
DNA Performance
Trading levels for DNA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.82 | 10.71% |
| R2 | 8.49 | 6.49% |
| R1 | 8.28 | 3.88% |
| Price | 7.97 | |
| S1 | 7.61 | -4.55% |
| S2 | 7.40 | -7.16% |
| S3 | 7.06 | -11.38% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.37 | 17.57% |
| R2 | 9.33 | 17.06% |
| R1 | 9.05 | 13.55% |
| Price | 7.97 | |
| S1 | 7.91 | -0.753% |
| S2 | 7.89 | -1.00% |
| S3 | 7.36 | -7.65% |
FAQ
Click here for our free guide on how to buy Ginkgo Bioworks Stock.
Buy DNA